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"Absolute compassion is the only thing that works" 
- From Dr. Solomon's Presentation to the NEGC 2015 Annual Meeting 
 
This work is dedicated in memory to Sondra Solomon, Ph.D., a lifelong advocate and leader in the research, 
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This annual report covers the activities of the New England Genetics Collaborative (NEGC) from June 1, 2014 to 
May 31, 2015. The purpose of this report is to provide the reader with additional documentation on the utilization 
of grant funds and what has been achieved as a result, to provide an overview of NEGC activities for both old and 
new partners, and to offer recommendations for the Collaborative's improvement and ultimate achievement of its 
mission and vision.  
 
Mission: The mission of the NEGC is to promote and improve the health and social well-being of those with inherited 
conditions through collaborations among public health professionals, private health professionals, educators, consumers and 
advocates in Maine (ME), New Hampshire (NH), Vermont (VT), Massachusetts (MA), Rhode Island (RI) and 
Connecticut (CT).  
 
Vision: All individuals with genetic conditions living in New England have the opportunity to achieve their fullest potential. 
 
This report includes: a summary of activities during the period; an update on the status of core project components 
from Year Eight; and recommendations to the project by the project evaluator. Members of the Collaborative 
Council were provided an opportunity to review and comment on the enclosed material. Evaluation of the project is 
led by Peter Antal, Ph.D., Institute on Disability, UNH. The current New England Regional Genetics and Newborn 
Screening Collaborative (NEGC) cooperative agreement (HRSA Grant # U22MC10980) officially began June 1, 
2007.  
 
During its eighth year of activity, core project staff members have focused on 1) dissemination of the ACA policy 
brief and development of a 2nd research stage; 2) expanding the number and quality of partnerships involved in the 
Quality Improvement initiative; 3) expanding the content and evaluation of the Genetics Education Materials for 
School Success( GEMSS) website; 4) completion of the CCHD project; 5) pursuing a range of best practices in 
effective transition supports; 6) launching a new medical home web series; 7) supporting alignment and integration 
of genetic resources among regional LEND programs; and 8) supporting multiple new training sessions, 
presentations and publications.  
 
In reviewing the goals and objectives for Year Eight, 97% of 38 objectives have either been fully successful (76%) 
or have made satisfactory progress (21%) in accordance with the long term goals of the grant. Of the remaining 
objectives, 3% are dependent on previous activities being completed or were not scheduled for this year, 0% did not 
make satisfactory progress, and 0% of activities were abandoned and resources reallocated. Feedback from the 
Annual Meeting held in Spring of 2015 (N=22) indicated strengths in several critical areas: the NEGC is headed in 
the right direction (100%), participants understood how their own work fits with the NEGC (95%), and participants 
had a good understanding of what the NEGC will accomplish in the following year (94%), and the NEGC has had 
tangible outcomes that have resulted in improvements in accessibility of high quality genetic services in the region 
(89%). Objectives for Year Nine have been shared and agreed to by project staff and chairs of the project’s work 
groups. In preparing to successfully meet the Collaborative's objectives, a summary review and recommendations 
for improvement have been identified in the final section of this report. 
  





The NEGC is staffed by John Moeschler, MD and Monica McClain, Ph.D., who serve as Co-Directors, Ms. Karen 
Smith as Project Coordinator, and Peter Antal, Ph.D. as Project Evaluator. Administrative support is provided by 
the UNH Institute on Disability, which acts as fiscal agent. 
In 2014 – 2015, the NEGC carried out substantial portions of its work through six Workgroups: Education and 
Outreach, Health Care Access & Financing, Medical Home, Quality Improvement, Transition, and NEGC/LEND. 
The chair of each Workgroup is a member of the Collaborative Council which facilitates coordination of 
Workgroup activities. The NEGC and Collaborative Council are guided by an Advisory Committee, which meets 
twice annually to help set direction for the collaborative and to provide feedback / raise issues throughout the year 
as needed.  Please see Appendix A for the current organizational chart. There were no changes in the staffing of key 
positions during Project Year Eight. 
Collaborative Activities 
 
Project staff continued to seek out new opportunities for partnerships with both regional and national partners. 
During Year Eight, this included: the NEGC Annual meeting, 17 presentations, 3 publications, a promotional video 
for GEMSS, an instructional video for the QI group, a new transition guide for mitochondrial disorders, and six 
training and technical assistance activities. Also this year, the NEGC continued its work on the CCHD project, and 
launched a new initiative to address workforce shortages in providing specialty care for those with genetic 
conditions. The following outlines each of these accomplishments in more detail. 
 
Annual Meeting, April 9-10, 2015 
 
The annual meeting was well attended by 64 people. Plenary sessions included a focus on Genomic Sequencing in 
the General Newborn Population by Caroline Weipert and Meghan Towne, the Psychosocial Correlates of Genetic 
Disorder Related Stigma by Sondra Solomon, and "Welcome to Holland"; the Impact on Parents of a Diagnosis of 
CCHD by Joanna Fanos. In addition, participants had the opportunity to talk with Joan Scott from HRSA and 
David Flannery from the National Coordinating Center, American College of Medical Genetics, around the 
potential for new models of genetic services as HRSA prepares for a new funding cycle. As with previous years, 
open workgroup meetings were held that enabled cross group and new stakeholder participation in the activities of 
individual workgroups.   These included: 
• Education and Outreach: The group focused on reviewing the GEMSS website, a new promotional video, a 
discussion of do not resuscitate content on the website, a new partnership with Global Genes, and 
sustainability.  
• Medical Home: Reviewed the new webinar series on care coordination, how to partner with other states in 
the region, and helping children with complex behavioral issues 
• Health Care Access & Finance: Started off with a special speaker, Gabrielle Orbaek White, from 
Community Catalyst who led the group on a discussion of health policy and advocacy. Following this, the 
group outlined initial strategies and content areas for its second family survey. 
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• Transition: The group reviewed regional and national updates, a presentation on Adult Health Issues by 
Farrah Rajib from Children's Hospital Boston, and a new app on Emotional Intelligence from Elizabeth 
Donovan from Bodimojo. 
• Quality Improvement: Seven clinical sites participated during this meeting, providing updates on their 
current efforts and planning out next steps for the future development of the group's activities. 
 
Among those providing feedback on the meeting evaluation forms (N=22), 94% agreed that they had an 
opportunity to share and contribute (6% unsure). All respondents (N=18) thought that the NEGC was headed in 
the right direction. There was slightly less than full agreement on four areas: NEGC has had tangible outcomes that 
have resulted in improvements in accessibility of high quality genetic services in the region (89%, N=19), 
respondent understands how their own work fits with the NEGC (95%, N=19), and respondent has a good 
understanding of what the NEGC will accomplish next year (94%, N=18). For those involved in the workgroup 
sessions, all stated that they found the sessions somewhat or very helpful, with most in each case indicating the 
experience was very helpful. 
 
Presentations and Publications Supported by the NEGC 
During Project Year Eight, NEGC coalition stakeholders provided 17 presentations across a diverse mix of 
presenters. 
• New England Children with Genetic Disorders and Health Reform: Information and Recommendations for State 
Policymakers 
o  Webinar, Sept. 2014 by Meg Comeau 
• NEGC Update 
o Consortium of Metabolic Programs Annual meeting; Boylston MA; Nov. 2014 by Karen Smith   
• “Moving on with Mito Overview” 
o Consortium of Metabolic Programs Annual meeting; Boylston MA; Nov. 2014 by 
Rob Auffrey 
• Quality Improvement in care provided by general genetics clinics and in care for patients with PKU and MCAD deficiency: 
project overview, methodology, and results to date 
o NCC/RC/PD Meeting, Washington, DC Nov. 2014 by John Moeschler 
•  HRSA MCHB Grants for CCHD – RC Partnership Opportunity (Dissemination of information/resources/products)”  
o NCC/RC/PD Meeting, Washington, DC, Nov. 2014 by Monica McClain 
• QI Developmental Delay Registry: What it takes to secure a diagnosis  
o NERGG Annual Meeting / Collaborative Session; Portsmouth, NH; Dec 4, 2014 by John Moeshler 
• The Affordable Care Act and Access to Genetic Services: Opportunities and Challenges 
o NERGG Annual Meeting / Collaborative Session; Portsmouth, NH; Dec 4, 2014 by Meg Comeau 
• GEMSS – Genetics Education Materials for School Success: Parent Voices. 
o AMCHP; Jan 2015 by Anne Dillon 
• Public Health Approaches for Implementing or Supporting Cascade Screening for Tier 1 Genetic Conditions 
o Public Health Special Interest Group, American College of Medical Genetics and Genomics, Salt 
Lake City, UT, March 2015 by Monica McClain 
• Returning to Therapy & the ACMG Diagnosis & Management Guidelines 
o American College of Medical Genetics, Salt Lake City, Utah (BioMarin, Pharmaceuticals) by Susan 
Waisbren 
• QI Developmental Delay Registry: What it takes to secure a diagnosis 
     
5 
o QI Special Interest Group, American College of Medical Genetics and Genomics, Salt Lake City, 
UT, March 2015 by John Moeschler 
• Welcome to Holland: The Impact on Parents of a Diagnosis of CCHD 
o NEGC Annual Meeting; Portsmouth, NH; April 2015 by Joanna Fanos 
• Living with Distinction: the Psychosocial Correlates of Genetic Disorder Related Stigma 
o  NEGC Annual Meeting; Portsmouth, NH; April 2015 by Sondra Solomon 
• Adult Health Issues 
o NEGC Annual Meeting; Portsmouth, NH; April 2015 by Farrah Rajib 
• Envisioning the Future – How GEMSS can Help! 
o NH Family Support Conference; May 2015 by Ann Dillon and three members of the GEMSS 
Action Group 
• Why Medical Home and Care Coordination are Important for Children” 
o Webinar;  May 2015 by Jill Rinehart, Jeanne McAllister 
• NEGC Genetics Workforce Project 
o NYMAC Summit; May 28th 2015 by Monica McClain  
 
By the end of Project Year Eight, three additional publications were created by NEGC collaborative council 
members. The most recent products include: 
 
Peer Reviewed Publications 
• McClain MR, McGrath R, Stransky ML, Benkendorf JL. National survey of providers treating patients with 
metabolic disorders identified by newborn screening demonstrates challenges faced by clinical care systems. Clin 
Pediatr, 2015 Jul;54(8):759-64.. 
• John B. Moeschler, MD, MS, FAAP, FACMG, Michael Shevell, MDCM, FRCP, COMMITTEE on 
GENETICS. Comprehensive Evaluation of the Child With Intellectual Disability or Global Developmental 
Delays.  Pediatrics, August 25, 2014 released online. 
• Longo N, Siriwardena K, Feigenbaum A, Dimmock D, Burton BK, Stockler S, Waisbren S, Lang W, Jurecki E, 
Zhang C, Prasad S. Long-term developmental progression in infants and young children taking sapropterin for 
phenylketonuria: a two-year analysis of safety and efficacy. 2014; Epub ahead of print. 
 
In addition to the above areas, the project was responsible for the support of a GEMSS promotional video, a 
Transition Guide for Mitochondrial Disorders, as well as instructional videos on QI registry changes. 
For a detailed listing of presentations and publications supported by the collaborative and its members, please see 
Appendix B and C, respectively. 
Trainings and Technical Assistance  
During Year 8, staff funded by the NEGC carried out six training and technical assistance activities to families, state 
staff, and others. Of the 133 aided in this manner, most were health providers and other professionals (111), 
followed by education providers (5), state MCH staff (5), community based organizations (5) and other (7). Areas of 
support provided included: a training to LEND trainees, an educational activity on cancer genetics management, a 
medical home webinar training, and collaboration with LEND trainees on projects related to GEMSS, the annual 
NEGC stakeholder survey, as well as the CCHD project. 
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Special Projects 
During Year 8, the NEGC continued to engage in the Critical Congenital Heart Disease (CCHD) screening project. 
The goal of the New England CCHD Newborn Screening Project is to develop processes for CCHD screening 
that will set the stage for improved health outcomes for newborns with CCHD, and their families. This 
collaborative project aims to enhance and expand existing networks among state public health departments and 
birthing facilities, and to share resources and expertise in developing CCHD newborn screening protocols, 
educational materials and programs, and program evaluation among five New England states: Maine, New 
Hampshire, Vermont, Rhode Island, and Connecticut. Support has been provided to clinical sites and public health 
newborn screening programs in a variety of ways, including financial, regular conference calls and in-person 
meetings, and sharing of local and national resources. This project received a no-cost extension to continue through 
May 2016., with 19 members serving on the project council across 5 New England States. As of April 2015,  48,294 
babies were screened, and 3 cases of CCHD were identified. 
Also during Year 8, NEGC initiated a new partnership with the Genetic Metabolic Center for Education (GMCE) 
that will come to fruition in Year 9. The purpose of this collaboration is to create a consulting and educational 
platform able to support the diagnosis and treatment of inherited metabolic disorders throughout New England.  
Collaborations with Regional and National Partners 
This section provides documentation on the affiliations held by NEGC management and collaborative council 
members with the intent of highlighting the connections members have to both regional and national initiatives 
which have parallel missions to the work of the NEGC.  
 
Supporting the National Coordinating Center 
 
• Evaluation: Peter Antal, Ph.D., Monica McClain, Ph.D., 
• Transition: Susan Waisbren, Ph.D., Karen Smith 
• Health Care Access and Financing: Monica McClain, Ph.D., Peter Antal, Ph.D., Meg Comeau, MHA 
 
Collaboration with Other Regional and National Groups 
 
• AAP - Genetics and Birth Defects: Leah Burke, MD 
• AUCD LEND Genetics Work Group, John Moeschler, MD 
• Catalyst Center, The National Center for Health Insurance Coverage and Financing For Children with 
Special Health Care Needs, Meg Comeau, MHA 
• Jackson Laboratories for Genomic Medicine, Monica McClain, PhD 
• Leadership Education in Neurodevelopmental and Related Disabilities (LEND):  John Moeschler, MD; 
Monica McClain, PhD; Wendy Smith, MD; Leah Burke, MD 
• New England Regional Genetics Group: Monica McClain, Ph.D., Karen Smith, Peter Antal, Ph.D., John 
Moeschler, MD, Greg Prazar MD 
• New England Consortium of Metabolic Programs: Susan Waisbren, Ph.D., Leah Burke, MD 
• Next Step: Susan Waisbren, Ph.D. 
• NH LEND: John Moeschler, MD 
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A Focus on the GEMSS Online Resource 
The GEMSS (Genetics Education Materials for School Success) site, initially launched in February 2012, has 
continued to experience rapid growth in content and high utilization (ranging from 1,103 unique users per month to 
2,357). During Year Eight, an estimated1 19,380 individuals visited the website (an increase of 45% over the 
previous year). These users had over 24,000 sessions and 74,000 pageviews.  Users represented all 50 states and 144 
countries / territories. 
 
























Project leaders have continued to seek out expertise and feedback from users, regional and national advocacy 
groups, as well as leaders in the field. By May 2015, the site added 4 new conditions (Congenital Heart Defects, 
Rubinstein-Taybi Syndrome, Smith-Magenis Syndrome, and Sotos Syndrome) and updated many existing 
conditions, bringing the total count of conditions covered to 36. 
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NEGC on the Web 
 
In 2014-2015, the NEGC and GEMSS were mobile optimized, the contact list for the NEGC was improved with 




During Year Eight, monthly visitors 
to the NEGC held fairly stable from 
June (161) through October (172), 
with a slight uptick during March 
(270) and April (247), when the 
NEGC held its annual meeting) - see 
Fig.1.2 Compared to the previous 
year, there were substantively more 
visitors to the NEGC (2,667 vs. 
1,901) and more sessions (3,525 vs. 
3,128). Over the course of these 12 
months, the average time spent on 
the website changed throughout the 
year, ranging from a low of 1:27 (November) to a high of 5:50 (July) with total page views ranging from 412 (Dec) 
to 1,540 (March).   
 
Sources of Referral to the NEGC Website
 
In looking across different referral sources to the website and the levels of activity generated (See Table 1), the most 
effective source (in terms of time spent on the site and a low bounce rate) was partner organization referrals, 
589 sessions generated and an average time of 5:53 (minutes:seconds) per visit, followed by Search engine results 
which generated more visits (1,006), but an average time of 2:12. Outside of UNH, the top five organizational 
drivers to the NEGC website were Genes in Life (88), the NCC (70), Maine Medical Center (55), CDC (20), and 
Clinica CURET (10). Of note, the GEMSS website generated 55 sessions to the NEGC. A total of 27 organizations 
(35 in Year 7) were identified as referral sources to the NEGC. O
Facebook in Year 8) accounted for 38 visits (only 6 in 2007), an average time of 1:23 seconds on the website and a 
bounce rate of 66%. 'Other' refers primarily to web market generated referrals or from o
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 Note: Data for December through February are estimates based on averages for the year due to a lack of data for this time per





























Fig. 1 NEGC Unique Users and Visits
June 2014 Through May 2015
 
 
f note, links driven by social media (primarily from 
ther unaffiliated sites. 
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Direct Link 609 67.7 812 3.94 3:49 61.9% 56.8% 
Partner Org 589 6.2 785 5.3 5:53 41.4% 36% 
Email Referral 12 0.7 16 1.8 1:21 25% 33.3% 
Search 1006 87.5 1341 3 2:12 77.4% 53.7% 
Social 42 0.8 56 1.6 1:15 71.4% 69% 











In comparing results between Years 8 and 7 using the Adjusted Sessions column, total sessions visits from direct 
links generated a slightly higher number of sessions and slightly improved in terms of effectiveness (more time per 
visit). Visitors driven by organizational partner referrals dropped by 148 sessions and had a slightly shorter visit 
time. The number of visits to the NEGC website that originated via organic search held stable in comparison to last 
year. Social driven visitors increased substantively (from 6 in the previous year to 56 in Year 8), but email referrals 
dropped (from 24 to 12).  
  
                                                           
3
 Adjusted Sessions adds in an estimate based on monthly averages for the three months of data that was missing from Google 
Analytics reports. 
4
 Bounce rate refers to percentage of initial visitors to a site who "bounce" away to a different site, rather than continue on to other 






Time % New 
Bounce 
Rate 
Direct Link 697 58.1  4.21 03:28.2 60% 48.9% 
Partner Org 933 3.98  5.52 06:28.1 42% 34% 
Email Referral 24 0.15  3.08 00:48.4 21% 33% 
Search 1,336 57.10  3.88 04:06.2 65.2% 51.1% 
Social 6 0.15  1.83 00:14.3 83.3% 66.7% 
Other 132 4.57  1.48 00:23.9 99% 93% 
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National Outreach of the NEGC 
Of 2,730 visits to the NEGC website over 9 months, 2,123 were from the US and 367 were from other countries. 
Of the US visits, about one-third were from New Hampshire (682)5. States with 50 or more visitors include: 
Massachusetts (238), New York (138), Maine (124), Maryland (110), Vermont (75), Connecticut (69), and California 
(61). Please see Fig.2. 














Resource Leveraging  
 
During Year Eight, NEGC staff did not submit any new grant applications for core or expanded activities. 
However, letters of support were written for:  
 
• ACMG’s policy recommendation letter re: payment for genetic testing, to the National Government 
Services Medical Policy Unit; Aug 2014 
• Federation for Children with Special Needs, MA, for their application for continued funding as Mass 
Family-to-Family Health Information Center; Dec 2014 
• ACMG’s application to HRSA to continue as NCC; Jan 2015 
• Adelaide Murray, work study, in her application for a scholarship from the Patient Advocate Foundation; 
Feb 2015 
   
For a complete list of resources leveraged to date, please see Appendix D. 
 
                                                           
5
 However, 432 (39%) of the NH traffic were generated from the city of Durham (where the administrative staff of the NEGC resides).   
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COMPLETION OF OBJECTIVES IN YEAR EIGHT (6/1/14 - 5/31/15) 
 
This section provides an overview of each workgroup's activities during Year Eight. For an across-the-board view 
of major highlights from each group, please see Appendix E. A record of when groups met during the course of the 
year is provided in Appendix F. 
 
Table 3 provides a complete list of the objectives set forth by project staff at the beginning of the project year (with 
modifications based on changes in the project) as well as the status of each objective as of June, 1, 2015. Measures 
of objective “status” relative to implementation over the course of the 5 year project are defined by the following 
key: 1. Completed as planned, 2. Completed - deviated substantially from plans, 3. In progress - satisfactory, 4. In 
progress - unsatisfactory, 5. Initiation of activity deferred, 6. Activity abandoned, 7. Not scheduled to initiate this 
period, 8. Insufficient documentation available.  Additionally, a review is provided on the relative success of the 
objectives during Project Year Six. Review results are defined as: 
 
 Successful (29 of 38): All definitions of success for an objective have been fully met or the results of the 
activity in question fulfill the intent of the measure. 
 Partially Successful (8 of 38): Definitions of success for the year only partially met. Although not fully 
realized, substantive progress has been made in a number of core areas with fulfillment of the goal expected 
by the next project year. 
 Unsuccessful (0 of 38): Although some work on an activity may have been done, primary components of an 
activity targeted for the year were not substantively addressed within the time period. Lack of success may 
be due to a number of factors, including lack of participation by certain groups, delays in timeline for other 
project components, and the need to shift project priorities such that other components could be fulfilled in 
Year Four. 
 NA - Activity abandoned (0 of 38). Project staff determined that the objective/activity in question was no 
longer applicable to their work and resources have been reallocated to other work of the NEGC. 
 NA - Future Activity (1 of 38). Engagement in the activity is dependent on completion of previous project 
objectives or not scheduled for the current year. 
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Table 3: Status of Goals and Objectives of the NEGC, Project Year 8 
Objective 1. ESTABLISH AND MAINTAIN NEGC 
No. Objective Project Status 
Yr. 8 Definition 
of Success 
Yr. 8 Results 
1.1 Continue implementation 
of core administrative 
supports to the NEGC 








Review:  Successful 
All core staff activities completed 
during course of year. 
1.2 Budget Management 3 Operating 
expenses for the 




Meetings are held regularly to 
review and supports provided 
when requested as resources allow.  
1.3 Continue close 








supported in the 
work they do and 






100% of workgroup participants 
felt satisfied with the progress 
their committee/workgroup made 
during the year. 
100% of Advisory members agree 
that there is a spirit of 
collaboration, that meetings are 
well run and productive, that the 
RC provides excellent support and 
responds effectively, and that the 
Advisory Committee provides 




Review: Partially Successful 
Management meetings were held 
multiple times per month, 0 
meetings of the collaborative 
council and one face to face and 
one phone meeting of the 
Advisory Committee was held. 
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1.4 Annual meeting 1 Meeting held, 
Participants 
understand and are 
satisfied with the 
progress of the 
NEGC. 
Review: Successful 
64 participated in the Year 8 
NEGC Annual meeting. Among 
those providing feedback on the 
meeting evaluation forms (N=22), 
all agreed that the NEGC was 
headed in the right direction. 89% 
felt that the NEGC had achieved 
tangible outcomes that resulted in 
improvements in genetic services 
in the region, 94% felt they 
understood what the NEGC 
would accomplish in the next year, 
and 95% understood how their 
own work would fit in. 





with being able to 
voice their 
opinions and feel 
that they've been 
heard.  
Review: Successful 
94% of respondents at the Annual 
Meeting indicated that they had an 
opportunity to share perspectives 
and contribute to the discussion. 
Members of Collaborative Council 
and Advisory Committee meetings 




NEGC web site 
utilization. 
Review: Successful 
During Year 8, unique users 
increased primarily during the 
annual meeting event. Compared 
to the previous year, total users 
accessing the NEGC site had 
increased by 766 (2,667 vs. 1,901). 
Website transition to a new 
infrastructure for improved use by 
staff and consumers.  
Facebook page likes increased to 
320 and Twitter followers 
increased to 171.  
Objective 2. NEGC/LEND: Link LEND program requirements for trainee skill development in technical assistance (TA) and 
continuing education (CE) to NEGC needs 
No. Objective Project Status Yr. 8 Definition Yr. 8 Results 
     
14 
of Success 
2.1 Continue to participate 
with AUCD ad hoc 
national LEND working 
group on Genetics 
Education 
3 Bi-directional flow 
of information 
established 






Multiple discussions continue to 
be held with directors of regional 
LEND programs to discuss 
opportunities for collaboration in 
an effort to meet trainee 
educational requirements. Efforts 
coordinated with national level 
activities between the annual 
AUCD and NCC meeting.  
 
2.2 Integrate with counselor 
training programs in New 
England (Boston Univ & 
Brandeis) 
3 Ongoing training 
program available 





LEND at Children's Hospital 
Boston is collaborating with 
Boston University and Brandeis to 
recruit genetic counseling student 
in LEND program. No other 
LEND programs are currently 
pursuing this area.  
2.4 Coordinate NE LEND 
trainees’ requirements in 
skill development for 







measures of quality 
and success of 
TA/CE 
Review: Partially Successful 
Three Leadership in Action 
activities were identified and 
pursued between the NH/Maine 
LEND program and the NEGC. 
No new collaboration activities 
were pursued with other LEND 
programs in the region. 
Objective 3. Education & Outreach: Continually improve and expand the Genetics Education Materials for School Success 
(GEMSS) website, and disseminate/promote this resource to a broad range of audiences 
No. Objective Project Status 
Yr. 8 Definition 
of Success 
Yr. 8 Results 







Four new conditions added during 
Year 8. 
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3.2 Develop a tool for 
families to access 
educational transition 
programs 
1 Report of findings 
Feedback received; 
checklist finalized 
Review:  Successful 
Information for GEMSS page on 
transition reviewed and updated 
3.3 Collaborate with 
Global Genes to 
develop “Rare Toolkit” 
for education  
 
3 Resource page for 
parents developed.  
Review: Partially Successful 
During Year 8, GEMSS and 
Global Genes collaborated on 
developing a new resource page. 
(completed in July of 2015 
(https://globalgenes.org/toolkits/
educationadvocacy/intro/). 









4 Parent Ambassadors participated 
during Year 8. Presentation made 
to AMCHP in 1/15. New 
promotional video developed with 
LEND trainee. Action group 
established within NH Leadership 
and presentation made to NH 
Family Support conference in May 
2015. Utilized GEMSS magnets 
and parent ambassador posters for 
dissemination materials. 
Objective 4. Medical Home: Continuously improve and expand the workforce needed to care for those children with disorders identified 
by NBS programs 
No. Objective Project Status 
Yr. 8 Definition of 
Success 
Yr. 8 Results 
4.1 Develop strategy to 
implement genetics in 
primary care 
 
1 Develop a series of 
webinars to facilitate 
the integration of 
genetics into primary 
care pediatrics. 
Review: Successful 
Critical partners were brought 
together and developed a plan for 
a series of 4 webinars on the 
integration of genetics in primary 
care. The first of four webinars 
was held in May 2015, with 60 
online participants. Jeanne 
McAllister and Dr. Jill Reinhardt 
presented. Most respondents 
(N=18) rated the presenters as 
either good or excellent. In terms 
of the usefulness and value of the 
webinar, 6% felt it was average, 
67% good, and 28% excellent. 
Fifteen of 18 felt that the 
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educational session will enhance 
their competence, influence their 
practice, and impact their patient 
outcomes. 
 
Objective 5. Transition: Continuously improve and expand the workforce needed to care for those children with disorders identified by 
NBS programs 
5.1 Develop strategy to 
establish why primary 
care doctors should 
take cases of young 
adults with genetic 
conditions 
3 Develop, distribute, 




Adult survey administered at 3 
condition-specific family 
conferences (summer of 2014), 
and continued to disseminate 
during Year 8. 
5.2 Develop strategy to 
obtain data on 
transition outcomes 
3 Include both 
qualitative and 
quantitative data; work 
in sync with NCC 
Transition work group 
to obtain outcomes 
Review: Successful 
Continued development of clinical 
policy to support transition 
activities at Children's Hospital 
Boston. Includes utilization of the 
ABAS screening tool (which was 
previously validated with NEGC 
support). Collaborating with the 
IBECM (Inborn Errors of 
Metabolism). Continued efforts to 
seek research funding to support 
this area.   
 
5.3 Develop transitions 
brochure on 
mitochondrial diseases. 
3 Brochures to be 
developed outlining 
important information 
for school personnel 
to understand in 




The Moving on with Mito 
educational resource was 
completed. 
 
5.2 Leadership Training  1 Youth complete the 
program and report 
high satisfaction 
Youth are engaged to 
become effective 
Review: Successful 
Face Forward Camp: 19 youth 
participated in the summer Face 
Forward event. Participants 
reported: an improvement in 
having the tools and skills needed 
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advocates. to be successful in school while 
managing their condition (53% pre 
to 76% post); a doubling of 
participants planning to see an 
adult care physician; and an 
increased perception that they are 
part of a community that 
understand their condition (63% 
increase). 
Support for a young adult to 
initiate a support group for adults 
with metabolic conditions. 
Homocystinuria group established 
to provide connections and 
support to participants. 
 
 
Objective 6.  Health Care Access and Financing: Engage and educate families, stakeholders, and decision makers in each New 
England state using existing information about coverage, costs, and benefits related to genetic conditions  / Assess family-based definitions of 
needed benefits and coverage related to genetic conditions and educate stakeholders on the potential implications of the research for accessing 
quality care within each state's policy environment 
No. Objective Project Status 
Yr. 8 Definition of 
Success 
Yr. 8 Results 
6.1 Creation of a new 
policy brief and 
webinar 
1 Key decision makers 
are better informed 
about the coverage, 
costs, and benefits of 
quality services for 
those with genetic 
conditions 
Review: Successful 
New policy brief released and 
webinar held in September 2014 
highlighting major findings from 
the HAF group's research. 
Webinar included 
recommendations on approaches 
to potentially address gaps in state 
service systems. 
6.3 Collaborate with 
regional Family Voices 
partner organizations 
to develop and 
disseminate new 
research to families,  
identify data points 
from the research 
speaking to state level 
1 Families are better 
prepared to self-
advocate for needed 
benefits to decision 
makers 
Review: Successful 
The policy brief was widely 
disseminated to contacts from the 
NEGC, the Institute on Disability 
at UNH, as well as our partners in 
the region. Positive feedback was 
received from those participating 
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issues in the webinar, as well as those 
receiving copies of the report, with 
multiple respondents on the 
stakeholder survey and annual 
meeting evaluations reflecting on 
the positive impact of this work. 
6.4 Development of survey 
questionnaire for 2nd 
research stage with a 
focus on assessing 
network adequacy 
3 New survey developed 
with input from core 
stakeholders. 
Review: Partially Successful 
During the course of the year, 
members of the HAF group 
developed a range of new topics to 
pursue and further clarified 
potential questions for the second 
survey round during the 2015 
annual meeting of the NEGC. 
6.5 Development of 
agreements with 
partner organizations 
in each state to identify 
potential participants 
to participate in the 
new survey  
3 Research pool created  Review: Successful 
 
Although formal written 
agreements were not put in place, 
the contact list for dissemination 
of the survey was expanded greatly 
during the year. 
6.6 Design  and implement 
research strategy 
3 Data collected 
 
Review: Partially Successful 
Initial discussions were held on 
how best to collect the 2nd round 
of data. These discussions 
continued into Year 9 and were 
finalized during the Summer of 
2015. 
Objective 7.  Quality Improvement: Engage all centers in continuous quality improvement of metabolic center care of patients with 
inborn errors of metabolism 
No. Objective Project Status 
Yr. 8 Definition of 
Success 
Yr. 8 Results 
7.1 Obtain human subjects 
review committee 
waivers and business 
associates agreement 
(BAAs) from all 
participating centers 
3 IRB exemptions 
obtained and BAAs are 
executed 
Review:  Successful 
Waivers and BAAs are filed with 
NEGC/UNH 
Obtained human subjects review 
committee waivers and BAAs 
from all centers entering data 
(N=5). Ten sites currently 
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participating in the overall process 
at varying levels of involvement. 
7.2 All centers have web-
portal access to registry 
3 Data entered into 
registry 
Review: Successful 
All participating centers have 
access to the registry.  
7.3 Data analysis 
 
3 Data are analyzed 
 
Review: Successful 
Available data was reviewed by 
NEGC staff and feedback 
provided to members of the 
collaborative Year 8. The registry 
has records for 1,669 individuals. 
7.4 Compare care 
processes to standard 
care guidelines. 
3 Collaboration made 
easy and user-driven 
Review: Successful 
Where standard care guidelines 
exist, these are incorporated into 
review processes of the group. For 
example, PKU guideline has been 
developed by the American 
College of Medical Genetics 
(includes W. Smith).  Will be used 
by Metabolism teams and NEGC 
to assess care practices in NE as 
new ones are identified. This is 
ongoing.  
 








improved via effective 




Webex utilized for online 
conferences.  
QI Registry vendor (GVT) has 
asynchronous orientation videos 
completed. Registry workflow 
video completed. 
Moeschler has 2 videos (using 
Camtasia Relay) on the principles 
of quality improvement and value 
creation in Medical Genetics 
completed. 
7.6 Test decision-support 
mobile app for 
3 Decision support app 
reviewed and made 
 





available to workgroup 
members 
Review: Successful 
All DDID QI sites are aware of 
the www.Treatable-ID.org 
decision support tool, and 
Dartmouth-Hitchcock Medical 
Center uses this decision support 
regularly. 
7.7 Meet requirements of 





 Regular information 
on family centered care 
in coordinated systems 
is integrated into the 
QI process  
Review: Successful 
ABMG has approved the NEGC 
QI for credit for Maintenance of 
Certification, Part IV. W. Smith 
successfully submitted this activity 
to ABMG. Other centers’ 
physicians plan to do same. 
7.8 Update registry with 





7 Expanded regional 




Registry to be updated once initial 
data collection stages are 
completed. 
7.9 Expand QI process to 
additional centers. 
3 Additional centers are 
added to the learning 
collaborative. 
Review: Partially Successful 
Recently added Baystate Medical 
Center, Springfield, MA, to the QI 
group for those referred with 
developmental delays and 
intellectual disability bringing the 
number of sites to five. Other sites 
have expressed an interest.  
As participation at the regional 
level strengthens, the NEGC plans 
to invite centers from other 
regions to participate in the 
collaborative. 
Objective 8. Public Health Infrastructure: Build capacity in state public health (PH) departments to enhance and sustain the 
delivery of newborn screening and follow-up and treatment services 
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No. Objective Project Status 
Yr. 8 Definition of 
Success 
Yr. 8 Results 
8.1 Pilot project: Critical 
congenital heart disease 
(CCHD) screening 





up and data collections 
protocols for each 
facility documented; 
Review: Successful 
Pilot project implemented for: 
Critical congenital heart disease 
(CCHD) newborn screening.   
The project has enrolled 9 birthing 
centers, developed a uniform 
screening protocol and 
disseminated a Tier 2 educational 
brochure for parents/families. As 
of April 2015, 48,294 babies were 
screened and 3 cases of CCHD 
were identified. 
Objective 9. QUANTITATIVE AND QUALITATIVE EVALUATIONS 
No. Objective Project Status 
Yr. 8 Definition of 
Success 
Yr. 8 Results 
9.1 Gather data on 
program activities and 
outcomes and provide 
ongoing feedback to 
project staff and 
funder on project 
progress. 
3 Management staff 
report evaluation 
support has been an 
effective aid in 
decision making and 
program improvement. 
Review: Successful 
Evaluation and survey data are 
used to inform NEGC activities. 
9.2 Conduct annual 
stakeholder survey 
3 A majority of 
stakeholders 
participate in the 





Review: Partially Successful 
Only 20% of stakeholders invited 
to participate in the survey did so. 
9.3 Complete annual 
reports which can be 
used by staff to 
improve project 
outcomes 
3 Reports completed and 
utilized by staff to 
improve project 
outcomes and utilized 
by stakeholders to stay 
informed of project 
Review: Partially Successful 
While information included in the 
Year 8 report was provided to 
management staff throughout the 
year, the report was not finalized 
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progress. until January of 2015. 
9.4 Participate on national 
outcome measurement 
efforts 





NEGC was represented on all 
meetings and provided 
information for all national level 
reporting and discussions. 
PLANS FOR NEGC YEAR 9 (6/1/15-5/31/16) 
 
Table 4 provides a list of objectives to be completed by each of the relevant workgroups and administrative teams 
for Cycle 2, Year Four of the NEGC project. The status of each objective will be updated by the Project Manager 
on a monthly basis during meetings with the various Workgroup chairs using the following key: 1. Completed as 
planned, 2. Completed - deviated substantially from plans, 3. In progress - satisfactory, 4. In progress - 
unsatisfactory, 5. Initiation of activity deferred, 6. Activity abandoned, 7. Not scheduled to initiate in period. 
Workgroup chairs have established a series of performance measures to document successful achievement of each 
of their objectives. 
Table 4: Year 9 Goals and Objectives 
Activity Outcome Outcome Indicator 
NEGC/LEND: Link LEND program requirements for trainee skill development in technical assistance (TA) and continuing 
education (CE) to NEGC needs 
Continue to participate with AUCD 
ad hoc national LEND working 
group on Genetics Education 
Bi-directional flow of information 
established (NEGC and ad hoc 
group); integration of national with 
regional  
Curricular materials agreed upon and 
implemented by program with 
“implementation reports” by each 
LEND  
Collaborate with Genetic Counselor 
training programs in NE (Boston U., 
Brandeis U.) 
Articulation of options between 
LEND programs and GC programs 
to co-recruit a GC student 
Written summary of co-recruitment 
and training plans 
Coordinate NE LEND trainees’ 
requirements in skill development for 
CE/TA with NEGC 
Shared understanding of TA/CE 
requirements and NEGC needs 
Implement measures of quality and 
success of TA/CE 
Number of CE/TA projects engaged 
in with LEND trainees. Satisfaction 
measures on quality of CE/TA. 
Education & Outreach: Continually improve and expand the Genetics Education Materials for School Success (GEMSS) website, 
and disseminate/promote this resource to a broad range of audiences 
Update GEMSS Conditions and supporting material 
updated 
Review by project evaluator. 
 
Develop resources for additional 
conditions 
Additional conditions content 
developed for GEMSS 
Conditions added to GEMSS website  
Promote and disseminate GEMSS  
via Parent Ambassadors and NH 
Parent Ambassadors trained and # Parent Ambassadors trained 
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Leadership enrolled.  
Families / Organizations receive 
information on GEMSS 
# of families / organizations 
outreached to by Parent 
Ambassadors and GEMSS Action 
group.  
Medical Home/Care Coordination: Continuously improve and expand the workforce needed to care for those children with 
disorders identified by NBS programs 
Implement genetics in primary care 
webinars 
Webinars implemented with high 
satisfaction ratings.  
# webinars held, # participants, 
satisfaction ratings of participants. 
Transition: Improve understanding and resources available to support successful transitions among youth 
Assess health in young adults with 
genetic and metabolic conditions 
Development and implementation of 
health survey incorporating modified 
Erikson Psychosocial Stage Inventory 
# of surveys distributed, analysis 
completed, report completed 
 
Complete transitions brochure on 
mitochondrial diseases 
  
Face Forward Camp Youth complete the program and 
report high satisfaction 
Youth are engaged to become 
effective advocates. 
# of youth participating / completing 
the Face Forward program, # youth 
reporting satisfaction with the 
program 
Develop strategy to obtain data on 
transition outcomes 
Include both qualitative and 
quantitative data; work in sync with 
NCC Transition work group to obtain 
outcomes 
# of new data collection efforts 
initiated to track transition outcomes 
Health Care Access and Financing: Engage and educate families, stakeholders, and decision makers in each New England state 
using existing information about coverage, costs, and benefits related to genetic conditions  / Assess family-based definitions of needed benefits 
and coverage related to genetic conditions and educate stakeholders on the potential implications of the research for accessing quality care 
within each state's policy environment 
Design  and implement research 
strategy for 2nd research stage 
Data collected 
 
# of responses collected; 
Data set created and analyzed 
Creation of a policy brief and web 
seminar highlighting findings from 
the 2nd research stage. 
Key decision makers are better 
informed about the coverage, costs, 
and benefits of quality services for 
those with genetic conditions 
# of representatives from key target 
groups participating in presentations 
and/or reviewing project documents 
(legislators, insurance groups, 
professional assoc), # of unique web-
based viewers 
Collaborate with regional Family 
Voices partner organizations to 
develop and disseminate material 
Families are better prepared to self-
advocate for needed benefits to 
decision makers 
Family feedback, stakeholder survey 
Quality Improvement – DD/ID Project: Engage all centers in continuous quality improvement of metabolic center care of patients 
with inborn errors of metabolism 
Obtain human subjects review 
committee waivers and BAAs from 
all centers 
IRB exemptions obtained and BAAs 
are executed 
Waivers and BAAs are filed with 
NEGC/UNH 
All centers have web-portal access to 
registry 
Data entered into registry # of patients for whom complete data 
are entered 
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Data analysis Data are analyzed Reports back to metabolic teams; # of 
publications 
Compare care processes to standard 
care guidelines. 
Collaboration made easy and user-
driven 
Best practices in care guidelines are 
reviewed by the group and 
incorporated as appropriate. 
Utilized modern social media and 
telecommunications to support 
quality improvement learning and 
action. 
Workgroup participation is improved 
via effective use of communication 
technologies. 
 
A range of technologies is utilized to 
enhance communication and 
participation among workgroup 
members 
Update registry with CSHCN data 
variables and additional performance 
indicators. 
 
Expanded regional capacity to adopt 
QI processes for metabolic centers 
Registry updated with CSHCN data 
variables and other performance 
measures as identified by the 
workgroup. 
Expand QI process to additional 
centers. 
Additional centers are added to the 
learning collaborative. 
# of regional and national centers 
added 
Public Health Infrastructure: Build capacity in state public health (PH) departments to enhance and sustain the delivery of newborn 
screening and follow-up and treatment services 
Pilot project: Critical congenital heart 
disease (CCHD) screening 
Completion of evaluation reports, 
development of resource page for 
children and families living with 
CCHD. 
Completion of evaluation report and 
NEGC resource page. 
 
  
     
25 
CONCLUSIONS AND RECOMMENDATIONS 
 
During Project Year Eight, the NEGC had a very productive year while also putting in place critical activities for 
completion in Year Nine. Among its key accomplishments:  
• Multiple discussion forums highlighting the implications of the HAF group's policy brief on the Affordable 
Care Act and outlining core components for a second research stage 
• Continued growth and utilization of the NEGC and GEMSS websites, including a new collaboration with 
Global Genes to develop a rare toolkit for education 
• Launching of a new medical home webinar series as well as a new effort to understand health concerns 
among adult patients living with genetic conditions 
• Continued development of the QI collaborative, a nationally unique partnership of 10 clinical sites which 
have partnered together to form  a learning community around improving the care of individuals living with 
DD/ID, PKU, and MCADD. To date, five of these clinics are regularly entering data into the DD/ID data 
registry, with 1,669 records entered. 
• A highly successful and informative annual meeting, where 89% of respondents felt that the NEGC had 
achieved tangible outcomes that resulted in improvements in genetic services in the region 
• Continuation of the CCHD project  to create an electronic resource with psychosocial supports for families 
and provide resource bags to parents at the time of diagnosis.  
• A new initiative to create and support a telehealth platform for New England hospitals and clinics that serve 
metabolic patients, 
• Substantive efforts were made to provide presentations and trainings this past year along with publishing 
research in peer reviewed journal articles (17 presentations, 5 publications, 6 CE/TA activities) 
 
In looking forward to future activities of the NEGC, there are a few areas that would be of value to review on a 
regular basis during project management meetings and to develop an action plan around in order to continue the 
NEGC's focus on improved outreach and impact: 
• Keeping the NEGC website current - it will continue to be helpful to establish and monitor a common time 
frame for when minutes should be reviewed by participants, finalized, and posted to the website (for 
example, within one week of approval by meeting participants). 
• Improve access and utilization of evaluation reports to help stakeholder have a more informed understanding of the 
work of the NEGC, its challenges and opportunities. While management staff were kept apprised of needed 
adjustments to the NEGC throughout the year, completion of the Year 8 report took longer than what was 
hoped for during the year. The goal for Year 9 activities will be to have an updated report available no later 
than 9/30/16.  
• Continue to build on and expand organizational partnerships by taking advantage of existing collaborations and 
identifying new ones in order to help drive more traffic to the NEGC websites. It would be helpful to 
review the sites that are and are not referring individuals to the NEGC and outreaching to those sites where 
the NEGC believes a natural partnership exists. 
• Identify resources that may be underutilized and develop a plan for improving access and utilization of these resources. Since its 
inception, the NEGC has been able to make a broad array of resources available - transition plans, toolkits, 
assessment resources, educational brochures, and the GEMSS website just to name a few. It would be 
helpful to review these resources in light of who and how many people are accessing them and identify 
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potential market gaps which could be filled if these resources were made more easily accessible (or more 
broadly marketed). 
• Address Sustainability Challenges for Core NEGC Activities. As the NEGC is nearing completion of its current 
five year cycle, it will be critical that clear strategies for sustainability be outlined and implemented in 
collaboration with NEGC stakeholders. In the event that future cycles do not fund some of these areas that 
have been identified as a clear need for our region, new supports should be identified to ensure their 
continuation beyond the life of the current grant. Such supports may take the form of new grant 
applications, internalizing activities within the structures of partner organizations, business sponsorships, 
and targeted fund raising. 
Respectfully Submitted, 
Peter Antal, Ph.D. 
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APPENDIX B: NEGC PRESENTATIONS LIST 
 
* New in Year Eight
Sharing Work on Project Activities 
* “NEGC Update”, Consortium of Metabolic 
Programs Annual meeting; Boylston MA;  
Nov. 2014.  
Karen Smith   
 
* “Moving on with Mito Overview”; Consortium of 
Metabolic Programs Annual meeting; Boylston 
MA; Nov. 2014. 
Rob Auffrey 
 
 * “Quality Improvement in care provided by general 
genetics clinics and in care for patients with PKU and 
MCAD deficiency: project overview, methodology, and 





 * “HRSA MCHB Grants for CCHD – RC 
Partnership Opportunity (Dissemination of 
information/resources/products)”;  




* “QI Developmental Delay Registry: What it takes to 
secure a diagnosis” NERGG Annual Meeting / 




* “GEMSS – Genetics Education Materials for School 
Success: Parent Voices.”  AMCHP; Jan 2015 
Anne Dillon 
 
* “Public Health Approaches for Implementing or 
Supporting Cascade Screening for Tier 1 Genetic 
Conditions” Public Health Special Interest Group, 
American College of Medical Genetics and 
Genomics, Salt Lake City, UT, March 2015 
Monica McClain 
 
* “QI Developmental Delay Registry: What it takes to 
secure a diagnosis” QI Special Interest Group, 
American College of Medical Genetics and 
Genomics, Salt Lake City, UT, March 2015 
John Moeschler 
 
* “NEGC Genetics Workforce Project”; NYMAC 
Summit; May 28th 2015 
Monica McClain  
 
The New England metabolic centers program to improve 
care for patients with inherited metabolic disorders. Society 
for Inherited Metabolic Disorders Annual 
Meeting, March 31 – April 3, 2012, Charlotte, NC. 
Smith W, Martin M, Greenstein RM, Korson M, 
Levy H, Waisbren SE, Moeschler JB, Cooley WC, 
McAllister JW, Antal P, McClain MR. 
 
Region 1 Quality Control Project: Multicenter Validation 
of Algorithms to Improve Communications of Positive 
Newborn Screening Results to the Medical Home.  
Secretary’s Advisory Committee on Heritable 
Disorders in Newborns and Children, Laboratory 
Standards and Procedures Subcommittee Meeting, 
May 2011, Washington, D.C.  
Sahai I, Caggana M, Morrissey M, Rodriguez D, 
Baker, M, Hoffman G, Sommers P, Manning A, 
Eaton R. 




Joint presentation by five Regional Genetics Collaboratives 
Association of Maternal and Child Health 




LTFU data on children diagnosed with long-chain 
hydroxyacyl-CoA dehydrogenase deficiency (LCHAD) by 
NBS. December, 2010, Portsmouth NH. 
Dr. Inderneel Sahai 
 
Presentation of Massachusetts data as a part of the CF 
NBS and Care Quality Improvement Short Course. 2010 
24th Annual North American Cystic Fibrosis 
Conference. October 21-23, 2010. Baltimore, MD. 
Dr. Anne Comeau 
 
A guide for the classroom for children with genetic 
conditions: preliminary needs assessment and development. 
National Coalition for Health Professional 
Education in Genetics Annual Meeting, Sept. 23-
24, 2010; Bethesda, MD. 
Dr. Leah Burke 
 
Update on LTFU activities in New England.  
NCC/RC PU Annual Meeting,  
November 17, 2009, Bethesda, MD.  




• NEGC Work Groups 
• Innovative Projects  
NEGC Annual Meeting 
Dec 2009 
 
Meet Your Neighbor: NEGC 




Poster Session: NEGC 
ACMG Meeting, Tampa, FL 
March 2009 
John Moeschler             
Poster session: NEGC 
NCC/RC Meeting, Bethesda, MD 
January 2009 




• NEGC Work Groups 
• Innovative Projects  
• CSHN Survey Analysis Presentation – Bob 
 McGrath 
NEGC Annual Meeting 
Dec 2008 
 
Long Term Follow up of Newborn Screening Conditions in 





Long Term Follow up of Newborn Screening Conditions in 





Long Term Follow up of Newborn Screening Conditions in 
New England ~ Maine NBS Advisory Committee 
September 2008 
Anne Comeau   
 
Educating Students 
Public Health and Genetics 




Class at UNH Graduate Program: Fundamentals of 
Public Health  
Fall 2008 
Amy Schwartz (co-faculty) 
 
Innovative Project: Patients as Teachers 
Multiple presentations to medical school students  
2007-2009 (2 funding cycles) 
Mark Korson, Tufts University, project PI 




Innovative Project: Nurse Educators Incorporate ANA 
Guidelines on Genetics 
Videotaped training module presentations, now 
available online 
2007-2008  
Susan Capasso, St. Vincent’s Academy, project PI 
 
Training Professionals 
* “The Affordable Care Act and Access to Genetic 
Services: Opportunities and Challenges”, NERGG 
Annual Meeting / Collaborative Session; 
Portsmouth, NH; Dec 4, 2014 
Meg Comeau 
 
* “New England Children with Genetic Disorders and 
Health Reform: Information and Recommendations for 
State Policymakers”. Webinar. Meg Comeau; Sept 
2014 
 
* Returning to Therapy & the ACMG Diagnosis & 
Management Guidelines, American College of Medical 




* ”Welcome to Holland: The Impact on Parents of a 
Diagnosis of CCHD”; NEGC Annual Meeting; 
Portsmouth, NH; April 2015 
Joanna Fanos 
 
* “Living with Distinction: the Psychosocial Correlates of 
Genetic Disorder Related Stigma”; NEGC Annual 
Meeting; Portsmouth, NH; April 2015 
Sondra Solomon 
 
* “Adult Health Issues”; NEGC Annual Meeting; 
Portsmouth, NH; April 2015 
Farrah Rajib 
 
* “Envisioning the Future – How GEMSS can Help!”; 
 NH Family Support Conference; May 2015 
Ann Dillon and three members of the GEMSS 
Action Group 
 
* “Why Medical Home and Care Coordination are 
Important for Children”; Webinar;  May 2015 
Jill Rinehart, Jeanne McAllister 
 
NBS Follow Up, Uniform Assessment Method, and 
Transition 
Presented to Genetic Counselors at Children’s 
Hospital Boston by Susan Waisbren, PhD; May 6, 
2014.  
 
Development of Educational Brochure for Mitochondrial 
Disease 
Presented to Health Communication Fellows & 
Preceptors at Emerson College by Robert Auffrey, 
under supervision of Susan Waisbren; May 2014.  
 
Adults Health Concerns: Are our young people aging 
prematurely? 
Presented to NEGC Transition Work Group at 
Annual Meeting by Susan Waisbren; April 16, 
2014.  
 
Uniform Assessment Method 
Oral presentation by Dr. Waisbren, PhD, at NE 
Consortium of Metabolic Programs annual 
meeting; Boston, MA; November 15, 2013.  
 
Cognitive Reserve and Establishing Identity in PKU and 
Galactosemia 
Oral presentation by Dr. Waisbren, PhD, at 
Albany Medical Center; Albany, NY; Oct. 5, 2013.  
 
Psychological Outcomes for Urea Cycle Disorders 
Oral presentation by Susan Waisbren, PhD; 
International UCD Consortium (I-SIMD); Spain; 
September 2013.  
 
   
  
 
The Adult Galactosemic Phenotype. 
Oral presentation by  Susan Waisbren, PhD, of 
paper published in JIMD in 2012 for which Dr. 
Waisbren received the Archibald Garrod award; I-
SIMD; September 2013.  
 
 2013 4th Annual Northern New England Symposium 
on Marfan Syndrome & Related Disorders, Booth 
displaying GEMSS and other NEGC materials, 
UVM COM, September 14, 2013 
 
Sickle cell community based collaborative research: the roles 
and experiences of sickle cell advocacy organizations. 
American College of Medical Genetics Annual 
Meeting, March 19-23, 2013; Phoenix, AZ. 
Pertillar V, Williams-Edwards D. 
 
Quality improvement in the clinical genetic evaluation of 
patients referred for global developmental delays/intellectual 
disabilities or autism. 
American College of Medical Genetics Annual 
Meeting, March 19-23, 2013; Phoenix, AZ. 
Moeschler JB, McClain MR, Burke LW, Dinulos 
MB, Smith R, Smith W, Miller P. 
 
Newborn screening and the potential for whole genomic 
screening of newborns: Parental response to true positive, 
false positive and inconclusive results. Grand Rounds at 
Rhode Island Hospital. January 2013. Susan 
Waisbren. 
 
“I am more than a diagnosis!" Impact of Personal 
Identity on Health Care Transitions for Young 
Adults with Special Health Care Needs. Got 
Transition Webinar Series, Webinar #6. 
November 2012. Susan Waisbren, Mallory Cyr. 
 
Transition to Independent Living.  Got Transition 
Webinar Series. Live from Face Forward Summer 
Conference for Youth, Ashland, MA. July 2012.  
Susan Waisbren, Mallory Cyr. 
 
Exploring the Role of the School Nurse as a Facilitator of 
Health Care Transition. Maine Nurses’ Association 
Summer Institute. July 2012. Carol Orton. 
 
Keynote to 2012 Galactosemia Foundation Conference;  
topic included Transition.  Dallas, TX. July 2012. 
Susan Waisbren. 
 
Genetics Education Materials for School 
Success(GEMSS). 
13th International Williams Syndrome Conference, 
July 2012; Boston, MA. 
Giummo C.   
 
Outcomes of clinical genetic evaluation of 186 patients 
referred for intellectual disability or global developmental 
delays of unknown cause.   
International Association for the Scientific Study 
of Intellectual Disabilities World Congress, July 9, 
2012; Halifax, Nova Scotia. 
Moeschler J. 
 
Caring for patients with metabolic disorders from positive 
newborn screen to year 1: provider workload, workflow, and 
issues for the medical genetics workforce. Association of 
American Medical Colleges Physician Workforce 
Research Conference, May 3-4, Washington, DC. 
McGrath RJ, Stransky M, Benkendorf J. 
 
Presented abstract on GEMSS as a poster at 
ACMG annual meeting and published in ACMG 
Annual Meeting Abstract book 
Dr. Leah Burke 
 
Post-Analytic Molecular Challenges: Algorithm 
development, Clinical interpretation, Reporting Data and 
Reporting Risk. CDC Molecular Training 
Workshop, Atlanta, GA, May 2012.  
Dr. Anne Comeau (oral presentation) 
 
Improved interpretation of newborn screening results using 
predictive indices. Mass General Hospital Genetics 
Conference, 2012, Boston, MA. 
Sahai, I. 




Long term outcomes in newborn screening; Pediatric 
Academic Society; May 1, 2012; Boston,  MA; 
Member of the pane. 
Dr. Susan Waisbren 
 
Long Term Outcomes in Newborn Screening; Levey 
Symposium; Boston, MA; April 2012, Waisbren, S. 
 
Genetics education materials for school success: a guide for 
the classroom for children with genetic conditions. 
American College of Medical Genetics Annual 
Meeting, March 27-31, Charlotte, NC. 
Burke LW, Burke B, Dillon AD, Giummo C, 
Larson F, Lavochkin M, Mulcahy E, Smith W, 
Tutko H, Williams-Edwards D. 
 
The New England metabolic centers program to improve 
care for patients with inherited metabolic disorders. Society 
for Inherited Metabolic Disorders Annual 
Meeting, March 31 – April 3, 2012, Charlotte, NC.  
Smith W, Martin M, Greenstein RM, Korson M, 
Levy H, Waisbren SE, Moeschler JB, Cooley WC, 
McAllister JW, Antal P, McClain MR. 
 
New England birth defects consortium: 6-state folic 
acid/multivitamin distribution project. National Birth 
Defects Prevention Network Annual Meeting, 
February 27-29, 2012, Arlington, VA. 
Miller S, Haberman D, Wall T, Mason C, Tu S, 
Brozicevic P, Davis K, Davis J, Viner-Brown S, 
Arias W, Higgins C, Anderka M. 
 
Long-Term outcomes and Management across the Lifespan; 
NIH conference: PKU Scientific Review 
Conference: State of the Science and Future 
Research Needs; Feb 2012, Bethesda, MD 
Dr. Susan Waisbren 
 
Transition Issues; Urea Cycle Disorder Consortium, 
Boston, MA, Jan 20, 2012,  
Waisbren, S.  
 
Transition as a Psychological Rite of Passage; New 
England Regional Genetics Group (NERGG) 
Annual Conference Collaborative Session; 
December  1, 2011; Portsmouth, NH; Waisbren, S. 
 
Quality Improvement. The 2011 Newborn Screening 
and Genetic Testing Symposium, San Diego CA, 
November 2011. 
Dr. Roger Eaton (Panel Leader) 
 
Multicenter validation of algorithsm to improve 
communications of positive NBS results to the medical 
home. Newborn Screening and Genetic Testing 
Symposium, Nov. 2011, San Diego, CA. 
Sahai, I. 
 
Factors that can Influence the Immunoreactive Trypsinogen 
(IRT) Concentrations on Dried Blood Spot Samples. The 
2011 Newborn Screening and Genetic Testing 
Symposium, San Diego CA, November 2011.  
Dr. Roger Eaton (poster presentation) 
 
The Long and Short of Newborn Screening for LCHAD: 
The New England Experience. The 2011 Newborn 
Screening and Genetic Testing Symposium, San 
Diego CA, November 2011. Dr. Inderneel Sahai 
(oral presentation) 
 
Congenital Hypothyroidism in Multiple Births. The 2011 
Newborn Screening and Genetic Testing 
Symposium, San Diego CA, November 2011. Dr. 
Inderneel Sahai (poster presentation) 
 
Outcomes of clinical genetic evaluation of 186 patients 
referred for intellectual disability or global developmental 
delays of unknown cause. American Society of Human 
Genetics Annual Meeting, October 11-15, 2011, 
Montreal, Canada. 
Moeschler JB, McClain MR, Burke LW, Dinulos 
MB, Smith R, Smith W, Miller P. 
 
LTFU and Transition Issues; Maine PKU Network: 
Family Weekend, September 2011  
 
Laboratory aspects of IRT screening: Quality assurance 
activities. Joint APHL and HRSA conference on 
IRT as a Biomarker for Cystic Fibrosis: Technical 
   
  
 
Issues and Challenges for Newborn Screening. 
Bethesda, MD, May 2011.  
Roger Eaton (oral presentation) 
 
Experiences with IRT analysis in New England.  Joint 
APHL and HRSA Conference on IRT as a 
Biomarker for Cystic Fibrosis: Technical Issues 
and Challenges for Newborn Screening. Bethesda, 
MD, May 2011. Roger Eaton (oral presentation) 
 
Parents’ role in specialty referrals: views from both sides of 
the exam table. Pediatric Academic Societies Annual 
Meeting, April 28-May 1, 2011, Denver, CO. 
Fischer SH, Cooley WC, Mazor KM, Dworetzky 
B, Stille CJ. 
 
Poster Session: Parents’ role in specialty referrals: views 
from both sides of the exam table. 
Pediatric Academic Societies Annual Meeting, 
April 28-May 1, 2011, Denver, CO.  
Fischer SH, Cooley WC, Mazor KM, Dworetzky 
B, Stille CJ.  
 
Poster Session: Notes from the front lines: psychosocial 
follow-up of newborn screening. 
ELSI Congress: Exploring the ELSI Universe, 
April 12-14, 2011, Chapel Hill, NC. 
Fanos JH.  
 
Neurocognitive Outcomes in PKU. 
South East Regional Genetics Group (SERGG), 
March 31, 2011 
New Orleans, LA (presented via webinar) 
Waisbren, S. 
 
Poster Session: The adult galactosemic phenotype.  
Society for Inherited Metabolic Disorders Annual 
Meeting, Feb 27-March 2, 2011; Pacific Grove, 
CA. 
Waisbren S.  
 
LTFU data on children diagnosed with long-chain 
hydroxyacyl-CoA dehydrogenase deficiency (LCHAD) by 
NBS. December, 2010, Portsmouth NH.  
Dr. Inderneel Sahai 
 
Presentation of Massachusetts data as a part of the CF 
NBS and Care Quality Improvement Short Course. 2010 
24th Annual North American Cystic Fibrosis 
Conference. October 21-23, 2010. Baltimore, MD. 
Dr. Anne Comeau 
 
“Surviving to Thriving: Improving Long-term Outcomes in 
Sickle Cell Disease.”  New England Conference 
sponsored by the Hemoglobin Workgroup. 
September 16 2010, Boston, MA. 
 
Poster Session: A guide for the classroom for children with 
genetic conditions: preliminary needs assessment and 
development. 
National Coalition for Health Professional 
Education in Genetics Annual Meeting, Sept. 23-
24, 2010; Bethesda, MD. 
Burke L.  
 
Workshop: Genotype-first or phenotype-first? How to balance 
laboratory testing with genetic evaluations. Plenary Presentation: 
“Clinical evaluation of patients with developmental delays, birth 
defects and other potential genetic disorders—why complete 
evaluation should precede genetic testing. 
American College of Medical Genetics, Annual 
Meeting. Ballroom C, Albuquerque Convention Center. 
Robert Saal MD and Yves Lacassie MD, hosts.  
March 25, 2010. 
John Moeschler 
 
Translating clinical guidelines into quality improvement: the New 
England Genetics Cooperative experience. 
American College of Medical Genetics, Annual 
Meeting. Quality Improvement Special Interest Group. 
Marc Williams, M.D., host. Albuquerque, N.M.  
March 24, 2010.  
John Moeschler 
 
Neurocognitive issues in PKU and Transition to Adult 
Care 





CF: recommendations to increase Newborn Screening 
efficiency.  
7th International Congress, Latin American 
Society of Inborn Errors of Metabolism and 
Neonatal Screening,  
   
  
 
December 7, 2009, Cancun, Mexico 
Anne Comeau 
 
Lectures given: Office-Based Evaluation of Children with 
Suspected Genetic or Metabolic Disorders.  
American Academy of Pediatrics Visiting Professor to 
the Georgia Academy of Pediatrics. The Diagnostic 
Evaluation of Children with Autism & Related 
Diagnoses.  
Amelia Island, FL. Host Paul Fernhoff, M.D. and 
Frank Bawyer, M.D., FAAP.  
June 18-19, 2009.  
John Moeschler 
 
Development of Collaborative Organizations.  
National Coordinating Center of the Newborn 
Screening and Genetics Collaborative meeting. 
Chicago, IL.  
June 5, 2009.  
John Moeschler 
 
Implementing AAP Developmental Screening Guidelines 
in the Primary Care Medical Home 




Genetic Health Care Quality Improvement.  
Annual Meeting of the National Newborn Screening 
and Genetics Coordinating Center, Bethesda MD.  
January 7, 2009.  
 John Moeschler 
 
DEM work group project: Family Health History 
Awareness 
Multiple presentations during pilot phase to health 
care community in NE, now available online 
2007-2009  
Meagan Krasner  
 
Incorporating Genetics Into the Medical Home 








The Primary Care Medical Home and the Care of 
Children with Metabolic Disorders 




Newborn Screening Molecular Training Workshop 
November 18-24, 2008 
Anne Comeau 
 
Newborn Screening and Genetic Testing Symposium  




International Conference for Adults and Children 




Transition: Psychosocial Considerations 




Innovative Project:  Sickle Cell Disease Life Skills 
Training to Improve Outcomes 
Multiple presentations to young adults in NE 
2007-2009 
Bill Kubicek, Next Step, project PI 
 
Communication of relative risk for cystic fibrosis following a 
positive newborn screening result. Newborn Screening 
and Genetic Testing Symposium, November 3-6, 
2008, San Antonio, TX 
Hale JE, Parad RB, Dorkin HL, Gerstle r, Lapey A 
O’Sullivan BP, Spencer, T, Yee W and Comeau 
AM. 
 
Quality measures enhanced by short and long-term follow up 
in a newborn screening program collaborating with multiple 
centers. 
University of Massachusetts Medical 
School/Commonwealth Medicine Conference, 
October 25, 2007, Worcester, MA. 
Hale JE, Parad RB, O’Sullivan BP, Quizon AI, 
Martin T, Yee W, Dorkin HL, Comeau AM. 




Quality measures enhanced by short and long-term follow up 
in a newborn screening program collaborating with multiple 
centers.  
21st Annual North American CF Conference 
October 3-5, 2007, Anaheim, CA. 
  Hale JE, Parad RB, O’Sullivan BP, Quizon AI, 





APPENDIX C: NEGC PUBLICATIONS LIST 
* New in Year Eight 
Peer-Reviewed Journal Articles 
1. * McClain MR, McGrath R, Stransky ML, Benkendorf JL. National survey of providers treating patients 
with metabolic disorders identified by newborn screening demonstrates challenges faced by clinical care 
systems. Clin Pediatr, in press. 
2. * John B. Moeschler, MD, MS, FAAP, FACMG, Michael Shevell, MDCM, FRCP, COMMITTEE on 
GENETICS. Comprehensive Evaluation of the Child With Intellectual Disability or Global 
Developmental Delays.  Pediatrics, August 25, 2014 released online. 
3. * Longo N, Siriwardena K, Feigenbaum A, Dimmock D, Burton BK, Stockler S, Waisbren S, Lang W, 
Jurecki E, Zhang C, Prasad S. Long-term developmental progression in infants and young children taking 
sapropterin for phenylketonuria: a two-year analysis of safety and efficacy. 2014; Epub ahead of print. 
4. McClain MR, Cooley WC, Keirns T, Smith A. A survey of the preferences of primary care physicians 
regarding the co-management with specialists of children with rare or complex conditions. Clinical 
Pediatrics, 2014; 53:562-6.  
5. Waisbren, S. “Uniform Assessment Method for Screening and Outcomes Research: Validation of the 
Adaptive Behavior Assessment System, 2nd edition (ABAS-2), and the Behavior Rating Inventory of 
Executive Function (BRIEF)”; submitted February, 2014.  
6. Christopher J. Stille, MD, MPH; Shira H. Fischer, MD, PhD; Nancy La Pelle, PhD; Beth Dworetzky, MS; 
Kathleen M. Mazor, EdD; W. Carl Cooley, MD. Parent Partnerships in Communication and Decision 
Making. Academic Pediatrics. March-April 2013; 13(2):122-132.  
7. Stille CJ, Fischer SH, LaPelle N, Dworetzky B, Mazor KM, Cooley WC. Parent partnerships in 
communication and decision making about subspecialty referrals for children with special needs. 
Academic Pediatrics, January, 2013. 
8. Waisbren SE, Potter NL, Gordon CM, Green RC, Greenstein P, Gubbels CS, Rubio-Gozalbo E, 
Schomer D, Welt C, Anastasoaie V, D'Anna K, Gentile J, Guo CY, Hecht L, Jackson R, Jansma BM, Li 
Y, Lip V, Miller DT, Murray M, Power L, Quinn N, Rohr F, Shen Y, Skinder-Meredith A, Timmers I, 
Tunick R, Wessel A, Wu BL, Levy H, Elsas L, Berry GT. The adult galactosemic phenotype. J Inherit 
Metab Dis. 2012. Mar;35(2):279-86. 
9. Fanos, J. New “first families”: the psychological impact of new genetic technologies. Genetics in 
Medicine, 2012 Feb;14(2):189-90. 
10. Cooley WC, Kemper AR, NCC Medical Home Workgroup.   An Approach to Family-Centered 
Coordinated Co-management for Individuals with Conditions Identified through Newborn Screening. 
Genetics in Medicine, 2012, in press  
11. Mitchell, M.L., Hsu, H.W., Sahai, I., & Massachusetts Pediatric Endocrine Work Group. (2011). The 
increased incidence of congenital hypothyroidism: Fact or fancy? Clinical Endocrinology, 75(6), 806-10. 
12. Sahai, I., Bailey, J.C., Eaton, R.B., Zytkovicz, T., & Harris, D.J. (2011). A near-miss: very long chain acyl-
CoA dehydrogenase deficiency with normal primary markers in the initial well-timed newborn screening 
specimen. Journal of Pediatrics, 1(1), 172. 
13. Kemper AR, Kus CA, Ostrander RA, Comeau AM, Boyle CA, Dougherty D, Mann MY, Botkin JR, 
Green NS. Implementing Point of Care Newborn Screening. Genetics in Medicine In press. 
   
  
 
14. Waisbren SE, Potter NL, Gordon CM, Green RC, Greenstein P, Gubbels CS, Rubio-Gozalbo E, 
Schomer D, Welt C, Anastasoaie V, D'Anna K, Gentile J, Guo CY, Hecht L, Jackson R, Jansma BM, Li 
Y, Lip V, Miller DT, Murray M, Power L, Quinn N, Rohr F, Shen Y, Skinder-Meredith A, Timmers I, 
Tunick R, Wessel A, Wu BL, Levy H, Elsas L, Berry GT. The adult galactosemic phenotype. J Inherit 
Metab Dis. 2012 Mar;35(2):279-86. Epub 2011 Jul 21. PubMed PMID: 21779791. 
15. McGrath RJ, Stransky ML, Cooley WC, Moeschler JB. National profile of children with Down Syndrome: 
disease burden, access to care, and family impact. J Pediatr. 2011  
16. Woo HC, Lizarda A, Tucker R, Mitchell ML, Vohr B, Oh W, Phornphutkul C. Congenital 
hypothyroidism with a delayed thyroid-stimulating hormone elevation in very premature infants: incidence 
and growth and developmental outcomes. J Pediatr. 2011;158(4):538-42. 
17. Gubbels CS, Maurice-Stam H, Berry GT, Bosch AM, Waisbren S, Rubio-Gozalbo ME, Grootenhuis MA. 
Psychosocial developmental milestones in men with classic galactosemia. J Inherit Metab Dis. 2011 
Apr;34(2):415-9. Epub 2011 Feb 25. PubMed  PMID: 21350966; PubMed Central PMCID: 
PMC3112026. 
18. Sahai I, Eaton RB, Hale JE, Mulcahy EA, Comeau AM. Long-term follow-up to ensure quality care of 
individuals diagnosed with newborn screening conditions: early experience in New England. Genet Med. 
2010;12(12 Suppl):S220-7. 
19. Hale JE, Parad RB, Dorkin HL, et al. Cystic fibrosis newborn screening: using experience to optimize the 
screening algorithm. J Inherit Metab Dis. 2010;33(Suppl 2):S255-61. 
20. Waisbren, S. Establishing a consortium for the Study of Rare Diseases: The Urea Cycle Disorders 
Consortium. Mol Genet Metab., Feb 2010; 100 (Suppl 1): S97-S105 
21. White DA, Waisbren S, van Spronsen FJ. The psychology and neuropathology of phenylketonuria. Mol 
Genet Metab. 2010;99(Suppl 1):S1-2. 
22. White DA, Waisbren S, van Spronsen FJ. Final commentary: a new chapter. Mol Genet Metab. 
2010;99(Suppl 1):S106-107. 
23. Waisbren S, White DA. Screening for cognitive and social-emotional problems in individuals with PKU: 
tools for use in the metabolic clinic. Mol Genet Metab. 2010;99(Suppl 1):S96-99. 
24. Koch R, Trefz F, Waisbren S. Psychosocial issues and outcomes in maternal PKU. Mol Genet Metab. 
2010;99(Suppl 1):S68-74. 
25. Brumm VL, Bilder D, Waisbren SE. Psychiatric symptoms and disorders in phenylketonuria. Mol Genet 
Metab. 2010;99(Suppl 1):S59-63. 
26. Moeschler JB, Amato RS, Brewster T, et al. Improving genetic health care: a Northern New England pilot 
project addressing the genetic evaluation of the child with developmental delays or intellectual disability. 
Am J Med Genet C Semin Med Genet. Aug 15 2009;151C(3):241-254. 
27. McGrath RJ, Laflamme DJ, Schwartz AP, Stransky M, Moeschler JB. Access to genetic counseling for 
children with autism, Down syndrome, and intellectual disabilities. Pediatrics. Dec 2009;124(Suppl 
4):S443-449. 
28. Homer CJ, Cooley WC, Strickland B. Medical home 2009: what it is, where we were, and where we are 
today. Pediatr Ann. Sep 2009;38(9):483-490. 
29. Cooley WC, McAllister JW, Sherrieb K, Kuhlthau K. Improved outcomes associated with medical home 
implementation in pediatric primary care. Pediatrics. Jul 2009;124(1):358-364. 
   
  
 
30. Waisbren SE, Levy HL, Noble M, et al. Short-chain acyl-CoA dehydrogenase (SCAD) deficiency: an 
examination of the medical and neurodevelopmental characteristics of 14 cases identified through 
newborn screening or clinical symptoms. Mol Genet Metab. Sep-Oct 2008;95(1-2):39-45. 
31. Waisbren SE. Expanded newborn screening: information and resources for the family physician. Am Fam 
Physician. Apr 1 2008;77(7):987-994. 
32. Prosser LA, Ladapo JA, Rusinak D, Waisbren SE. Parental tolerance of false-positive newborn screening 
results. Arch Pediatr Adolesc Med. Sep 2008;162(9):870-876. 
33. Hsu HW, Zytkovicz TH, Comeau AM, et al. Spectrum of medium-chain acyl-CoA dehydrogenase 
deficiency detected by newborn screening. Pediatrics. May 2008;121(5):e1108-1114. 
34. Anastasoaie V, Kurzius L, Forbes P, Waisbren S. Stability of blood phenylalanine levels and IQ in 
children with phenylketonuria. Mol Genet Metab. Sep-Oct 2008;95(1-2):17-20. 
Chapters 
Fanos JH, Wiener L, Brennan T. Potential impact of genomic information on childhood sibling relationships. 




1. * GEMSS Promotional Video, Project Year 8 
2. * Transition Guide for Mitochondrial Disorders, Project Year 8 
3. Instructional videos on QI registry changes for participating Centers 
4. An Educator’s Guide to Urea Cycle Disorders, was posted in June 2013  
5. Educator’s Guide to PKU  (2013-2014) 
6. Educator’s Guide to Urea Cycle  Disorders (2012-2013) 
7. Educator’s Guide to MCAD (2011-2012) 
8. Transition Toolkit (2010-2011) 
9. Understanding Galactosemia (2009-2010) 
10. Galactosemia – Resources for Educators (2009-2010) 
11. Moving Forward – Your Guide to Galactosemia and Primary Ovarian Insufficiency (POI) (2009-
2010) 
12. A Guide for Prenatal Educators (2008-2009) 
13. Newborn Screening Brochures in Multiple Languages  (2008-2009) 
 
Reports 
1. New England Children with Genetic Disorders and Health Care Reform: Information and 
Recommendations for State Policymakers (May, 2014) 
2. Metabolic Phase II Final Report (May 2012) 
3. Metabolic  Workforce Phase One Report (April 2011) 
4. State Laws of New England: Use and Disclosure of Genetic and Newborn Screening Information for 
the Purposes of Treatment, a Registry, and Research (M. Winchester, Oct 2010) 
                     
   
  
 
APPENDIX D: NEGC Grant Applications 
 
Direct Applications 
Grant Name Description Amount 
Genomic Information and 
Clinical Decision Tools to 
Prevent Colorectal Cancer  
Submitted in response to RFA-
HG-13-004 – Genomic 
Medicine Pilot Demonstration 
Projects. Seeks to improve the 
evidence base needed to 
support universal Lynch 
syndrome screening, expand 
and link existing Lynch 
syndrome screening efforts, 
identify barriers and harmonize 
best practices. 
$3,739,047 for 4 years. 
NOT FUNDED 
HRSA; “A Regional Approach to 
CCHD NBS Implementation” 
Project Yr 5. The goal of this 
project is to develop processes for 
CCHD screening that will set the 
stage for improved health 
outcomes for newborns with 
CCHD, and their families. This 
collaborative project aims to 
enhance and expand existing 
networks among state public 
health departments and birthing 
facilities, and to share resources 
and expertise in developing critical 
congenital heart disease (CCHD) 
newborn screening protocols, 
educational materials and 
programs, and program evaluation 
among five New England states: 
Maine (ME), New Hampshire 
(NH), Vermont (VT), Rhode 
Island (RI) and Connecticut (CT). 
FUNDED $900,000 over three 
years.   
  HRSA; “Secondary data analysis to 
describe long-term follow-up of disorders 
identifiable by newborn screening” 
Project Yr 5. Newborn screening 
(NBS) has been described as one 
of the greatest public health 
successes; however, little is known 
about the clinical histories and 
Amount sought: $99,352. NOT 
FUNDED 
   
  
 
subsequent health care of those 
infants identified with a disorder.  
The primary specific aim of this 
project is to describe the patterns 
of health care, health care 
utilization, and total paid claims 
for infants and children with a 
disorder that is identifiable by 
NBS. 
NHGRI; “Universal screening for 
Lynch Syndrome”; 
Project Yr 5. The over-arching 
goal of this project is to develop 
methods for, and evaluate the 
feasibility of, incorporating an 
individual patient’s genomic 
findings, into his or her clinical 
care via the electronic health 
record when available, or by other 
acceptable methods when an 
electronic health record is not 
available.  This project will collect 
the outcomes data necessary to 
provide evidence of reduced 
mortality and morbidity in at-risk 
relatives of probands identified 
through Lynch syndrome 
screening programs 
Amount sought for 4 year grant: 
$3,743,130; NOT FUNDED 
Natural History of Disorders 
Identifiable by NBS 
Project Yr 4. NIH. Collaborate 
with NYMAC to assess natural 
history of several targeted 
conditions in order to create a 
stronger foundation for improving 
care. 
NOT FUNDED 
Administrative Supplemental Project Yr 3. HRSA; funds for 
legal analysis work and creation of 
the learning collaborative. 
$45,000 FUNDED 
June 2010 
Administrative Supplemental Project Yr 2. HRSA; funds for QI 
data registry and electronic 
medical record pilot 
$75,000 FUNDED 
April 09 
Assess capacity of genetic 
workforce 
Project Yr 2. ACMG; assess 
genetic workforce in light of 
expanded NBS; Bob McGrath will 
$36,000 FUNDED 
April 09 




Down Syndrome Surveillance 
 
Project Yr 2. CDC; 4 yr grant for 
$400,000 to study prevalence of 
DS at birth and older ages; 
overview of health across lifespan; 
Bob McGrath, David LaFlamme, 
IOD will collaborate 
NOT FUNDED 
 
Genetics Health Care Quality 
Improvement Project: A Multi-
State Pilot Collaboration 
Project Yr 2. AHRQ; $300,000 for 
2 yrs QI activities 
NOT FUNDED 
 
Dartmouth Translational Research 
Center 
Project Yr 2. Submitted by John 
Moeschler to supplement QI 
project 
NOT FUNDED 
Galactosemia and Premature 
Ovarian Insufficiency 
Project Yr 2. AUCD; 
collaboration with Susan 






APPENDIX E. SUMMARY OF WORKGROUP MILESTONES YEAR 8 (6/1/14-5/31/15) 
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APPENDIX F. WORKGROUP MEETINGS YEAR 8 (6/1/14-5/31/15) 
 
* The Collaborative Council met in June of 2015. 
**NCC Transition work group has monthly calls/NEGC wg met face to face at Met Consortium in Nov at NEGC 




























Management X  X X X X X X X X X X X 
Advisory 
Committee 
      X     X   
Collaborative 
Council* 
            
Quality 
Improvement 
   X       X   
Education & 
Outreach 
X X X   X  X  X X X 
NEGC/ 
LEND 




 X X X X X  X X X X   
Transition** X X  X X X/X X X X X X/X X 
Medical Home X X   X X X X X X X X 
               
 
 
APPENDIX G. COMMONLY USED ACRONYMS 
 
• AC: Advisory Committee 
• ACMG: American College of Medical Genetics 
• AUCD - UCEDDs: Association of University Centers on Disabilities - University Centers for 
Excellence in Developmental Disabilities Education 
• BAA: Business Associates Agreement 
• CC: Collaborative Council 
• CCHD: Critical Congenital Heart Disease 
• CSHCN: Children with Special Health Care Needs 
• GEMSS: Genetics Education Materials for School Success 
• GPCI: Genetics in Primary Care Institute 
• GVT: Global Vision Technologies 
• HAF: Health Care, Access, and Financing Workgroup 
• HRSA: Health Resources and Services Administration 
• IOD: Institute on Disability, University of New Hampshire 
• LEND: Leadership in Neurodevelopmental Disabilities 
• NECMP: New England Consortium of Metabolic Programs 
• NEGC: New England Regional Genetics and Newborn Screening Collaborative 
• NERGG: New England Regional Genetics Group 
• NCC: National Coordinating Center 
• QI: Quality Improvement 
• UNH: University of New Hampshire 
• WG: Workgroup 
 
